Report Detail
Global Circulating Tumor Cell Diagnostics Market Professional Survey Report 2019
- RnM3720633 |
- 03 September, 2019 |
- Global |
- 124 Pages |
- QYResearch |
- Pharma & Healthcare
Circulating tumor cells are significantly useful in determining the status of disease progression rate and projection of therapy needed for tumor eradication. Further development of various tumor markers that can be used along with companion diagnostics to diagnose or monitor various forms of cancer are expected to boost usage rates of CTC tests in the coming years.
Circulating tumor cell detection test possesses the ability to detect, quantify, and analyze tumor cells in the blood of cancer patients. It includes enrichment, detection and analysis of the detected circulating tumor cells. Circulating tumor cells tests are applicable in the characterization of tumor cells through biochemical marker analysis. CTC isolation, detection, and molecular characterization systems find investigational application in prostate, breast, colon, head, neck, skin, lung, and pancreatic cancer
Growing incidences oncology diseases and the introduction of novel biotechnological methods that enable the isolation and quantitation of circulating tumor cells. Furthermore, other factors like early disease diagnosis, cost savings on multiple treatments, drug safety, patient compliance, and optimization of therapies are attributive for rising demand for the preventive medicine, thus influencing the demand for CTC tests.
On course of the forecast period it is expected that over 150 companion diagnostic on-label combinations and a range of personalized therapeutic drugs under clinical trials and development pipelines based on companion diagnostics. The level of adoption of companion diagnostics is expected to significantly increase after these obtain complete FDA approval and are commercialized fully.
The global Circulating Tumor Cell Diagnostics market was valued at 4990 million US$ in 2018 and will reach 10100 million US$ by the end of 2025, growing at a CAGR of 9.2% during 2019-2025.
This report focuses on Circulating Tumor Cell Diagnostics volume and value at global level, regional level and company level. From a global perspective, this report represents overall Circulating Tumor Cell Diagnostics market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Circulating Tumor Cell Diagnostics in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Circulating Tumor Cell Diagnostics manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.
The following manufacturers are covered:
Janssen Diagnostics
Advanced Cell Diagnostics
Aviva Biosciences
Biocept Inc
Biofluidica Inc.
CellTraffix Inc.
Clearbridge BioMedics Pte Ltd
Epic Sciences Inc.
Fluxion Biosciences Inc.
ScreenCell
Silicon Biosystems
Sysmex Corporation
Greiner Bio-One GmbH
AdnaGen AG
Apocell Inc
Biocep Ltd
Canopus Bioscience Ltd
Creatv Microtech Inc
Ikonisys Inc
IV Diagnostics Inc
Miltenyi Biotech GmbH
Nanostring Technologies Inc
Rarecells Diagnostics.
Vitatex Inc
Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India
Segment by Type
CTC Enrichment
CTC Detection
CTC Analysis
Segment by Application
Tumorigenesis research
EMT biomarkers development
Cancer stem cell research
Others
Table of Contents
Executive Summary
1 Industry Overview of Circulating Tumor Cell Diagnostics
- 1.1 Definition of Circulating Tumor Cell Diagnostics
- 1.2 Circulating Tumor Cell Diagnostics Segment by Type
- 1.2.1 Global Circulating Tumor Cell Diagnostics Production Growth Rate Comparison by Types (2014-2025)
- 1.2.2 CTC Enrichment
- 1.2.3 CTC Detection
- 1.2.4 CTC Analysis
- 1.3 Circulating Tumor Cell Diagnostics Segment by Applications
- 1.3.1 Global Circulating Tumor Cell Diagnostics Consumption Comparison by Applications (2014-2025)
- 1.3.2 Tumorigenesis research
- 1.3.3 EMT biomarkers development
- 1.3.4 Cancer stem cell research
- 1.3.5 Others
- 1.4 Global Circulating Tumor Cell Diagnostics Overall Market
- 1.4.1 Global Circulating Tumor Cell Diagnostics Revenue (2014-2025)
- 1.4.2 Global Circulating Tumor Cell Diagnostics Production (2014-2025)
- 1.4.3 North America Circulating Tumor Cell Diagnostics Status and Prospect (2014-2025)
- 1.4.4 Europe Circulating Tumor Cell Diagnostics Status and Prospect (2014-2025)
- 1.4.5 China Circulating Tumor Cell Diagnostics Status and Prospect (2014-2025)
- 1.4.6 Japan Circulating Tumor Cell Diagnostics Status and Prospect (2014-2025)
- 1.4.7 Southeast Asia Circulating Tumor Cell Diagnostics Status and Prospect (2014-2025)
- 1.4.8 India Circulating Tumor Cell Diagnostics Status and Prospect (2014-2025)
2 Manufacturing Cost Structure Analysis
- 2.1 Raw Material and Suppliers
- 2.2 Manufacturing Cost Structure Analysis of Circulating Tumor Cell Diagnostics
- 2.3 Manufacturing Process Analysis of Circulating Tumor Cell Diagnostics
- 2.4 Industry Chain Structure of Circulating Tumor Cell Diagnostics
3 Development and Manufacturing Plants Analysis of Circulating Tumor Cell Diagnostics
- 3.1 Capacity and Commercial Production Date
- 3.2 Global Circulating Tumor Cell Diagnostics Manufacturing Plants Distribution
- 3.3 Major Manufacturers Technology Source and Market Position of Circulating Tumor Cell Diagnostics
- 3.4 Recent Development and Expansion Plans
4 Key Figures of Major Manufacturers
- 4.1 Circulating Tumor Cell Diagnostics Production and Capacity Analysis
- 4.2 Circulating Tumor Cell Diagnostics Revenue Analysis
- 4.3 Circulating Tumor Cell Diagnostics Price Analysis
- 4.4 Market Concentration Degree
5 Circulating Tumor Cell Diagnostics Regional Market Analysis
- 5.1 Circulating Tumor Cell Diagnostics Production by Regions
- 5.1.1 Global Circulating Tumor Cell Diagnostics Production by Regions
- 5.1.2 Global Circulating Tumor Cell Diagnostics Revenue by Regions
- 5.2 Circulating Tumor Cell Diagnostics Consumption by Regions
- 5.3 North America Circulating Tumor Cell Diagnostics Market Analysis
- 5.3.1 North America Circulating Tumor Cell Diagnostics Production
- 5.3.2 North America Circulating Tumor Cell Diagnostics Revenue
- 5.3.3 Key Manufacturers in North America
- 5.3.4 North America Circulating Tumor Cell Diagnostics Import and Export
- 5.4 Europe Circulating Tumor Cell Diagnostics Market Analysis
- 5.4.1 Europe Circulating Tumor Cell Diagnostics Production
- 5.4.2 Europe Circulating Tumor Cell Diagnostics Revenue
- 5.4.3 Key Manufacturers in Europe
- 5.4.4 Europe Circulating Tumor Cell Diagnostics Import and Export
- 5.5 China Circulating Tumor Cell Diagnostics Market Analysis
- 5.5.1 China Circulating Tumor Cell Diagnostics Production
- 5.5.2 China Circulating Tumor Cell Diagnostics Revenue
- 5.5.3 Key Manufacturers in China
- 5.5.4 China Circulating Tumor Cell Diagnostics Import and Export
- 5.6 Japan Circulating Tumor Cell Diagnostics Market Analysis
- 5.6.1 Japan Circulating Tumor Cell Diagnostics Production
- 5.6.2 Japan Circulating Tumor Cell Diagnostics Revenue
- 5.6.3 Key Manufacturers in Japan
- 5.6.4 Japan Circulating Tumor Cell Diagnostics Import and Export
- 5.7 Southeast Asia Circulating Tumor Cell Diagnostics Market Analysis
- 5.7.1 Southeast Asia Circulating Tumor Cell Diagnostics Production
- 5.7.2 Southeast Asia Circulating Tumor Cell Diagnostics Revenue
- 5.7.3 Key Manufacturers in Southeast Asia
- 5.7.4 Southeast Asia Circulating Tumor Cell Diagnostics Import and Export
- 5.8 India Circulating Tumor Cell Diagnostics Market Analysis
- 5.8.1 India Circulating Tumor Cell Diagnostics Production
- 5.8.2 India Circulating Tumor Cell Diagnostics Revenue
- 5.8.3 Key Manufacturers in India
- 5.8.4 India Circulating Tumor Cell Diagnostics Import and Export
6 Circulating Tumor Cell Diagnostics Segment Market Analysis (by Type)
- 6.1 Global Circulating Tumor Cell Diagnostics Production by Type
- 6.2 Global Circulating Tumor Cell Diagnostics Revenue by Type
- 6.3 Circulating Tumor Cell Diagnostics Price by Type
7 Circulating Tumor Cell Diagnostics Segment Market Analysis (by Application)
- 7.1 Global Circulating Tumor Cell Diagnostics Consumption by Application
- 7.2 Global Circulating Tumor Cell Diagnostics Consumption Market Share by Application (2014-2019)
8 Circulating Tumor Cell Diagnostics Major Manufacturers Analysis
- 8.1 Janssen Diagnostics
- 8.1.1 Janssen Diagnostics Circulating Tumor Cell Diagnostics Production Sites and Area Served
- 8.1.2 Janssen Diagnostics Product Introduction, Application and Specification
- 8.1.3 Janssen Diagnostics Circulating Tumor Cell Diagnostics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.1.4 Main Business and Markets Served
- 8.2 Advanced Cell Diagnostics
- 8.2.1 Advanced Cell Diagnostics Circulating Tumor Cell Diagnostics Production Sites and Area Served
- 8.2.2 Advanced Cell Diagnostics Product Introduction, Application and Specification
- 8.2.3 Advanced Cell Diagnostics Circulating Tumor Cell Diagnostics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.2.4 Main Business and Markets Served
- 8.3 Aviva Biosciences
- 8.3.1 Aviva Biosciences Circulating Tumor Cell Diagnostics Production Sites and Area Served
- 8.3.2 Aviva Biosciences Product Introduction, Application and Specification
- 8.3.3 Aviva Biosciences Circulating Tumor Cell Diagnostics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.3.4 Main Business and Markets Served
- 8.4 Biocept Inc
- 8.4.1 Biocept Inc Circulating Tumor Cell Diagnostics Production Sites and Area Served
- 8.4.2 Biocept Inc Product Introduction, Application and Specification
- 8.4.3 Biocept Inc Circulating Tumor Cell Diagnostics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.4.4 Main Business and Markets Served
- 8.5 Biofluidica Inc.
- 8.5.1 Biofluidica Inc. Circulating Tumor Cell Diagnostics Production Sites and Area Served
- 8.5.2 Biofluidica Inc. Product Introduction, Application and Specification
- 8.5.3 Biofluidica Inc. Circulating Tumor Cell Diagnostics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.5.4 Main Business and Markets Served
- 8.6 CellTraffix Inc.
- 8.6.1 CellTraffix Inc. Circulating Tumor Cell Diagnostics Production Sites and Area Served
- 8.6.2 CellTraffix Inc. Product Introduction, Application and Specification
- 8.6.3 CellTraffix Inc. Circulating Tumor Cell Diagnostics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.6.4 Main Business and Markets Served
- 8.7 Clearbridge BioMedics Pte Ltd
- 8.7.1 Clearbridge BioMedics Pte Ltd Circulating Tumor Cell Diagnostics Production Sites and Area Served
- 8.7.2 Clearbridge BioMedics Pte Ltd Product Introduction, Application and Specification
- 8.7.3 Clearbridge BioMedics Pte Ltd Circulating Tumor Cell Diagnostics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.7.4 Main Business and Markets Served
- 8.8 Epic Sciences Inc.
- 8.8.1 Epic Sciences Inc. Circulating Tumor Cell Diagnostics Production Sites and Area Served
- 8.8.2 Epic Sciences Inc. Product Introduction, Application and Specification
- 8.8.3 Epic Sciences Inc. Circulating Tumor Cell Diagnostics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.8.4 Main Business and Markets Served
- 8.9 Fluxion Biosciences Inc.
- 8.9.1 Fluxion Biosciences Inc. Circulating Tumor Cell Diagnostics Production Sites and Area Served
- 8.9.2 Fluxion Biosciences Inc. Product Introduction, Application and Specification
- 8.9.3 Fluxion Biosciences Inc. Circulating Tumor Cell Diagnostics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.9.4 Main Business and Markets Served
- 8.10 ScreenCell
- 8.10.1 ScreenCell Circulating Tumor Cell Diagnostics Production Sites and Area Served
- 8.10.2 ScreenCell Product Introduction, Application and Specification
- 8.10.3 ScreenCell Circulating Tumor Cell Diagnostics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.10.4 Main Business and Markets Served
- 8.11 Silicon Biosystems
- 8.12 Sysmex Corporation
- 8.13 Greiner Bio-One GmbH
- 8.14 AdnaGen AG
- 8.15 Apocell Inc
- 8.16 Biocep Ltd
- 8.17 Canopus Bioscience Ltd
- 8.18 Creatv Microtech Inc
- 8.19 Ikonisys Inc
- 8.20 IV Diagnostics Inc
- 8.21 Miltenyi Biotech GmbH
- 8.22 Nanostring Technologies Inc
- 8.23 Rarecells Diagnostics.
- 8.24 Vitatex Inc
9 Development Trend of Analysis of Circulating Tumor Cell Diagnostics Market
- 9.1 Global Circulating Tumor Cell Diagnostics Market Trend Analysis
- 9.1.1 Global Circulating Tumor Cell Diagnostics Market Size (Volume and Value) Forecast 2019-2025
- 9.2 Circulating Tumor Cell Diagnostics Regional Market Trend
- 9.2.1 North America Circulating Tumor Cell Diagnostics Forecast 2019-2025
- 9.2.2 Europe Circulating Tumor Cell Diagnostics Forecast 2019-2025
- 9.2.3 China Circulating Tumor Cell Diagnostics Forecast 2019-2025
- 9.2.4 Japan Circulating Tumor Cell Diagnostics Forecast 2019-2025
- 9.2.5 Southeast Asia Circulating Tumor Cell Diagnostics Forecast 2019-2025
- 9.2.6 India Circulating Tumor Cell Diagnostics Forecast 2019-2025
- 9.3 Circulating Tumor Cell Diagnostics Market Trend (Product Type)
- 9.4 Circulating Tumor Cell Diagnostics Market Trend (Application)
- 10.1 Marketing Channel
- 10.1.1 Direct Marketing
- 10.1.2 Indirect Marketing
- 10.3 Circulating Tumor Cell Diagnostics Customers
11 Market Dynamics
- 11.1 Market Trends
- 11.2 Opportunities
- 11.3 Market Drivers
- 11.4 Challenges
- 11.5 Influence Factors
12 Conclusion
13 Appendix
- 13.1 Methodology/Research Approach
- 13.1.1 Research Programs/Design
- 13.1.2 Market Size Estimation
- 13.1.3 Market Breakdown and Data Triangulation
- 13.2 Data Source
- 13.2.1 Secondary Sources
- 13.2.2 Primary Sources
- 13.3 Author List
Summary:
Get latest Market Research Reports on Circulating Tumor Cell Diagnostics. Industry analysis & Market Report on Circulating Tumor Cell Diagnostics is a syndicated market report, published as Global Circulating Tumor Cell Diagnostics Market Professional Survey Report 2019. It is complete Research Study and Industry Analysis of Circulating Tumor Cell Diagnostics market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
